Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors
Guardado en:
Autores principales: | Lars Erik Kristensen, Daniel Furst, Torkell Ellingsen, Sabrina Mai Nielsen, Simon Tarp, Esben Malm, Johannes Berg, John P. A. Ioannidis, Josef S. Smolen, Peter C. Taylor |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9196ff20813c4eef86045066de5c80ca |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Interstitial Lung Disease in Connective Tissue Diseases: Survival Patterns in a Population-Based Cohort
por: Charlotte Hyldgaard, et al.
Publicado: (2021) -
Harmful algae
Publicado: (2002) -
First, do no harm: The patient's experience of avoidable suffering as harm
por: Ashley Bauer
Publicado: (2018) -
Screening for chronic kidney disease: preventing harm or harming the healthy?
por: Maarten W Taal
Publicado: (2012) -
Staying focused on protecting young people from the harms of tobacco smoke
por: Mark W Vander Weg
Publicado: (2021)